Horizon Therapeutics plc Expands Medidata Partnership

Medidata has announced its expanded partnership with Horizon Therapeutics plc. Starting with one technology solution, Medidata will provide a suite of solutions for Horizon’s clinical research needs in multiple therapeutic areas including ophthalmology, rheumatology, and nephrology.

Horizon will access a broad range of clinical trial solutions using the Medidata Rave Clinical Cloud. Horizon will use Medidata’s Intelligent Trials product, which brings artificial intelligence, partnered with advanced analytics, to bring cross-industry real-time performance metrics, predictive models, and forecasting capabilities for trial planning and execution.

For more information, click here.